ATE110725T1 - Organische salze von physostigminderivaten. - Google Patents

Organische salze von physostigminderivaten.

Info

Publication number
ATE110725T1
ATE110725T1 AT88104977T AT88104977T ATE110725T1 AT E110725 T1 ATE110725 T1 AT E110725T1 AT 88104977 T AT88104977 T AT 88104977T AT 88104977 T AT88104977 T AT 88104977T AT E110725 T1 ATE110725 T1 AT E110725T1
Authority
AT
Austria
Prior art keywords
derivatives
organic salts
physostigmin
organic
anion
Prior art date
Application number
AT88104977T
Other languages
English (en)
Inventor
Pier Giuseppe Pagella
Pier Luigi Rugarli
Riccardo Bernardi
Massimo Pomponi
Mario Brufani
Stefano Maiorana
Carlo Meroni
Original Assignee
Mediolanum Farmaceutici Srl
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl, Consiglio Nazionale Ricerche filed Critical Mediolanum Farmaceutici Srl
Application granted granted Critical
Publication of ATE110725T1 publication Critical patent/ATE110725T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/145—Maleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT88104977T 1987-04-03 1988-03-28 Organische salze von physostigminderivaten. ATE110725T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8719964A IT1225462B (it) 1987-04-03 1987-04-03 Sali organici di derivati della fisostigmina

Publications (1)

Publication Number Publication Date
ATE110725T1 true ATE110725T1 (de) 1994-09-15

Family

ID=11162687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88104977T ATE110725T1 (de) 1987-04-03 1988-03-28 Organische salze von physostigminderivaten.

Country Status (10)

Country Link
US (1) US4978673A (de)
EP (1) EP0298202B1 (de)
JP (1) JPH0826023B2 (de)
KR (1) KR960007865B1 (de)
AT (1) ATE110725T1 (de)
CA (1) CA1331616C (de)
DE (1) DE3851279T2 (de)
ES (1) ES2060616T3 (de)
IE (1) IE64617B1 (de)
IT (1) IT1225462B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5177101A (en) * 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
IT1244746B (it) * 1991-02-14 1994-08-08 Laboratorio Chimico Int Spa Procedimento per la preparazione dell'1,3a,8,-trimetil-1,2,3,3a,8,-8a-esaidro pirrol (2,3-b) indolo-5(3as,8ar)-eptilcarbammato
EP0513703A3 (en) * 1991-05-13 1993-01-13 Magis Farmaceutici S.P.A. Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle
IT1251166B (it) * 1991-08-09 1995-05-04 Chiesi Farma Spa Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
US5171750A (en) * 1991-09-26 1992-12-15 The United States Of America As Represented By The Department Of Health And Human Services Substituted phenserines as specific inhibitors of acetylcholinesterase
US5206260A (en) * 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
GB9205670D0 (en) * 1992-03-16 1992-04-29 Indena Spa New derivatives of physostigmine,their use and pharmaceutical formulations containing them
NZ248180A (en) * 1992-07-21 1995-02-24 Hoechst Roussel Pharma Process for the preparation of physostigmine carbamate derivatives
IT1276928B1 (it) * 1995-10-13 1997-11-03 Angelini Ricerche Spa Processo migliorato per produrre eptastigmina e nuovo intermedio utile allo scopo
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6495700B1 (en) * 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
EP1604686A1 (de) * 2004-06-08 2005-12-14 Axonyx, Inc. Verwendung von Phenserine und einem HMG CoA reduktase Hemmer zur Verzögerung der Alzheimer Krankheit
WO2011100373A1 (en) 2010-02-09 2011-08-18 The Johns Hopkins University Methods and compositions for improving cognitive function
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神***病を処置するための方法および組成物
HUE036280T2 (hu) 2012-12-13 2018-06-28 H Lundbeck As Vortioxetint és donepezilt tartalmazó készítmények
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use

Also Published As

Publication number Publication date
IT8719964A0 (it) 1987-04-03
KR880012602A (ko) 1988-11-28
IE880960L (en) 1988-10-03
JPS6425777A (en) 1989-01-27
US4978673A (en) 1990-12-18
DE3851279D1 (de) 1994-10-06
IT1225462B (it) 1990-11-14
EP0298202B1 (de) 1994-08-31
JPH0826023B2 (ja) 1996-03-13
KR960007865B1 (ko) 1996-06-13
ES2060616T3 (es) 1994-12-01
IE64617B1 (en) 1995-08-23
CA1331616C (en) 1994-08-23
DE3851279T2 (de) 1995-02-09
EP0298202A1 (de) 1989-01-11

Similar Documents

Publication Publication Date Title
ATE110725T1 (de) Organische salze von physostigminderivaten.
NO933376D0 (no) Morfinan-derivater og medisinsk anvendelse derav
GR3004018T3 (de)
DK543787D0 (da) Antibakterielle midler
DK24389D0 (da) (cycloalkylamino)methylenbis(phosphonsyre) og farmaceutiske praeparater indeholdende forbindelsen
NO871990L (no) Quinolinkarboksylsyre-derivater.
FI875666A (fi) Menetelmä terapeuttisesti aktiivisen kinoliiniyhdisteen valmistamiseksi
GB8828669D0 (en) Organic compounds
TNSN90042A1 (fr) Procede de preparation des derives de la thieno-triazolo- diazepine
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
DE3770724D1 (de) Thiazolidin-4-one-derivate un deren saeure-additionssalze.
DE69201761D1 (de) Verfahren zum Herstellen von Alpha-fluorierten Acrylaten.
ATE142620T1 (de) 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität
DE69119714D1 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
FI893505A (fi) Foerfarande foer framstaellning av substituerade quanyltioureaderivat.
ES2036613T3 (es) Fungicidas que contienen aminocompuestos.
FI824298L (fi) N,n-disubstituerade alkenamider och fenylalkenamider, deras framstaellningsfoerfaranden och anvaendning som laekemedel
DK579489A (da) Heterocykliske forbindelser
NO175255C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylestere av 2-(4-(2-piperidino-etoksy)-benzoyl)-benzosyre med forgrenet kjede
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee